Notably, recent studies have uncovered a diverse transcriptional profile of PRMT1-derived circRNAs [23] and elucidated the complex regulatory roles of non-coding RNA in the cell cycle progression of breast cancer [24], underpinning our investigation into specific non-coding RNAs and their potential as novel therapeutic targets of breast cancer. The gene discussed is PRMT1; the disease is breast cancer.